Nutrex-Hawaii Introduces Its #1 Selling BioAstin® Hawaiian Astaxanthin® in a Retail-Ready, Sugar-Free, Vegan Gummy Format
28 Marzo 2024 - 4:05AM
Business Wire
The new gummy offers an industry-leading 12mg of Hawaiian
Astaxanthin® per serving – 6000 times the antioxidant power of
Vitamin C – with science-backed, multifunctional benefits and a
40-year legacy of farm-direct transparency and traceability.
Nutrex-Hawaii, Inc., a wholly owned subsidiary of Cyanotech
Corporation, unveils its #1 selling BioAstin® Hawaiian Astaxanthin®
dietary supplement in a groundbreaking sugar free gummy format,
enriched with an industry-leading 12mg of natural Hawaiian
Astaxanthin per daily serving.
At the forefront of natural microalgae innovation, Nutrex-Hawaii
addresses the evolving preferences of today's discerning consumers
with its new gummies, offering a host of distinct benefits:
- Sourced from natural Hawaiian microalgae grown outdoors under
natural sun – never synthetic, fermented, nor cultivated in
laboratory environments, as much of today’s astaxanthin is
sourced,
- Backed by scientific research supporting comprehensive, full
body health objectives of today’s consumer,
- Grown in Hawaii, ensuring unparalleled origin traceability and
sustainability.
"Today's consumers seek brands that align with their values of
efficacy, transparency, and sustainability. With our demonstrated
40-year legacy of Hawaiian microalgae production and innovation,
we're enthusiastic about providing a safe, responsible, and
sustainable solution that caters to the growing global interest in
gummies with multi-functional benefits," stated Collette Kakuk,
Chief Strategic and Commercial Officer. "Our new BioAstin® Hawaiian
Astaxanthin® gummies offer consumers a convenient way to experience
the benefits of our number 1 selling brand, in an easy to consume
and tasty gummy format.”
BioAstin®, derived from natural Hawaiian Astaxanthin®, is a
powerful natural antioxidant extracted from Haematococcus pluvialis
algae, renowned for its tangible health benefits for diverse health
goals, including not only healthy agers, but also active lifestyle
and beauty from within audiences. The benefits of BioAstin®
Hawaiian Astaxanthin® are supported by longstanding, robust
clinical science, encompassing eye, skin, joint, and heart health,
as well as healthy inflammatory response and post-exercise
recovery☨.
"With antioxidant potency 6000 times greater than Vitamin C, our
BioAstin® Hawaiian Astaxanthin® gummies provide consumers with
powerful benefits for full body wellness. Our 12mg formulation sets
our gummies apart from others in the market, including exciting
skin health claims important to consumers today, such as improving
moisture retention and hydration☨, reducing appearance of
wrinkles☨, and also skin health during UV and sun exposure☨," added
Kakuk.
The gummies are further enhanced with 25mcg (1000 IU) of vitamin
D3, and are sugar free, sweetened with monk fruit and stevia,
non-GMO, gluten-free, and vegan.
The new gummies were soft launched at the recent Natural
Products Expo West and are currently being nationally rolled out in
mass and specialty retail channels and are also available on
Amazon.com and https://www.nutrex-hawaii.com.
For more information about Nutrex-Hawaii and BioAstin® Hawaiian
Astaxanthin® gummies, please visit
https://www.nutrex-hawaii.com.
About Nutrex-Hawaii, Inc.: Nutrex-Hawaii, a wholly
owned subsidiary of Cyanotech Corporation, is the global leader in
natural, premium microalgae dietary supplements for health and
wellness, leading the natural channel category with its BioAstin®
Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica® brands. All
Nutrex-Hawaii microalgae products are naturally and sustainably
produced on a purpose-built 96-acre facility in Kona, Hawaii.
Distributed through premium retail locations in the United States,
including Whole Foods, Sprouts, Costco, and online at Amazon.com
and https://www.nutrex-hawaii.com, Nutrex-Hawaii products are
trusted by consumers worldwide.
☨These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnosis, treat,
cure or prevent any disease.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240328602781/en/
Felicia Ladin (808) 334-9455 investorrelations@cyanotech.com
Cyanotech (NASDAQ:CYAN)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Cyanotech (NASDAQ:CYAN)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025